Masterflex SE (MZX)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 13.10 |
|---|---|
| 52-week range | 12.05 – 14.85 |
| Return, 1 month / 3 months | −4.7% / −8.1% |
| Return, 1 year / 3 years | −3.0% / +86.8% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 26.8% |
| Worst drawdown (1 year) | -16.9% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Masterflex SE is a German manufacturer of flexible hose and tubing systems and related components. The company makes hoses, connectors and moulded parts from plastics and metals, serving industrial customers in fields such as medical technology, food processing, chemicals and machinery. Its products are used to move gases, liquids and powders in demanding environments. Masterflex is based in Gelsenkirchen, Germany, and supplies manufacturers and equipment builders in Europe and beyond.
The shares are listed on the XETRA Stock Exchange in Germany under the code MZX, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Masterflex SE (MZX) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 13.10 on 23 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 341 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.0% and over the last three months it fell 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.1% | ||
| From 52-week high | -11.8% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.1% | ||
| 6-month return | -3.7% | ||
| 12-month return, skipping the last month | 1.8% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.9% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | −4.7% |
| 3 months | −8.1% |
| 6 months | −3.7% |
| 1 year | −3.0% |
| 3 years | +86.8% |
| 5 years | +122.2% |
Signals
| 50-day / 200-day average | 13.78 / 13.81 |
|---|---|
| Golden / death cross (60 days) | Death, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | EUR 0.3000 |
| 13 Jun 2025 | EUR 0.2700 |
| 8 Jul 2024 | EUR 0.2500 |
| 13 Jun 2024 | EUR 0.2500 |
| 8 Jun 2023 | EUR 0.2000 |
| 15 Jun 2022 | EUR 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.